In the past, scientists have linked dietary polysaccharides to the treatment of type 2 diabetes, finding that they can effectively reduce pancreatic β-cell dysfunction and lower blood glucose by enhancing insulin-related signaling pathways, but little research has been conducted into the processes that cause this outcome. The gene discussed is INS; the disease is type 2 diabetes mellitus.